Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Pericoronary Fat in Stage 4 CKM Syndrome
NCT07351643Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in acute coronary syndrome (ACS), sponsored by General Hospital of the Northern Theater Command. Started Jun 2026; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07351643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07351643.